Skip to main content
HLS Therapeutics Inc. logo

HLS Therapeutics Inc. — Investor Relations & Filings

Ticker · HLS ISIN · US40390B3078 LEI · 549300QKXFY1J71L2D68 TSX Wholesale and retail trade
Open in API
Filings indexed 364 across all filing types
Latest filing 2021-05-06 Interim / Quarterly Rep…
Country CA Canada
Listing TSX HLS

About HLS Therapeutics Inc.

https://hlstherapeutics.com/

HLS Therapeutics Inc. is a specialty pharmaceutical company focused on the acquisition and commercialization of branded medicines across North America. The company targets products that address unmet needs, primarily in the treatment of psychiatric disorders and cardiovascular disease/risk reduction. Its commercial-stage portfolio includes CLOZARIL® (clozapine) for psychiatric disorders and VASCEPA® (icosapent ethyl) for cardiovascular risk reduction. HLS also commercializes NILEMDO® (bempedoic acid) and NEXLIZET® (bempedoic acid/ezetimibe combination) for the reduction of LDL-cholesterol in patients at risk of cardiovascular disease. HLS ensures reliable market access to these essential therapies by sourcing products directly from originators and best-in-class manufacturing partners.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis for the Three Months Ended March 31, 2021' and contains detailed financial and operational discussion for a quarterly period. It includes financial metrics, forward-looking statements, and operational updates typical of an MD&A section accompanying interim financial statements. The document length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The content focuses on the three-month period ending March 31, 2021, which aligns with an interim or quarterly report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2021
2021-05-06 English
News release - English.pdf
Call Transcript Classification · 85% confidence The document is a press release announcing the upcoming release of Q1 2021 financial results and a conference call to discuss those results. It includes details about the date, time, dial-in numbers, webcast link, and replay information for the call. There is no actual financial data or detailed financial report included in the text. The document is essentially an announcement of an event (conference call) related to financial results, not the results themselves or a transcript. Therefore, it fits best as a Call Transcript (CT) category since it is about a conference call event, but since it is only an announcement of the call and not the transcript itself, it is more appropriate to classify it as a Regulatory Filing (RNS) as a general announcement. However, given the specific categories, the best fit is Call Transcript (CT) because it is about a financial results conference call. Confidence is high because the document clearly states it is about a conference call for Q1 2021 financial results and provides call details, which is typical for a Call Transcript announcement.
2021-04-22 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 90% confidence The document is a confirmation notice from TSX Trust Company regarding the record and meeting dates for the upcoming Annual General Meeting (AGM) of HLS Therapeutics Inc. It specifies the meeting date, record date, classes of securities entitled to vote, and proxy-related material delivery details. The document does not contain the AGM materials themselves, nor does it include financial data or voting results. It is a notification about the AGM logistics rather than the AGM presentation or report. Given the short length (1948 characters) and the nature of the content, this fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related notices about the AGM. However, since this is a confirmation of notice and meeting dates rather than the AGM materials themselves, it is best classified as AGM Information (AGM-R) because it directly relates to the AGM event details rather than being a general regulatory filing or report publication announcement.
2021-04-19 English
News release - English.pdf
Investor Presentation Classification · 90% confidence The document is a press release announcing the company's participation in upcoming investor conferences. It contains no financial data, no report content, and no regulatory filing details. It is an announcement about investor presentations rather than the presentations themselves or any financial report. The document length is short (1965 characters), and it does not contain any detailed financial or management information. Therefore, the best fitting category is Investor Presentation (IP) as it relates to investor-focused events and presentations.
2021-04-15 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from HLS Therapeutics commenting on a new regulation enacted by the Quebec Health Minister affecting access to a drug support program. It discusses regulatory and policy issues, patient access, and requests a meeting with the minister. There are no financial statements, no detailed financial performance data, no earnings results, no management discussion of financial results, no audit information, no shareholder voting results, no capital or financing updates, no legal proceedings, no merger or acquisition activity, and no other regulatory filings typical of financial or corporate filings. The document is a public relations communication or announcement related to regulatory and healthcare policy matters. It does not fit into any of the specific financial or corporate filing categories such as Annual Report, Earnings Release, Management Reports, or Regulatory Filings that involve compliance or officer certifications. Given the content and format, the best fitting category is Regulatory Filings (RNS) as a general regulatory announcement and public statement that does not fit other categories.
2021-04-01 English
News release - English.pdf
Regulatory Filings
2021-03-29 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.